TABLE OF CONTENTS
| | | | Volume 31, Issue 39 (September 2012) | | In this issue Review Original Articles
Also new AOP
| | | | Advertisement | | | | | Review | Top | | Epigenetic cancer therapy: rationales, targets and drugsM Rius and F Lyko Oncogene 2012 31: 4257-4265; advance online publication, December 19, 2011; 10.1038/onc.2011.601 Abstract | Full Text | | Original Articles | Top | | CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypesM Niemelä, O Kauko, H Sihto, J-P Mpindi, D Nicorici, P Pernilä, O-P Kallioniemi, H Joensuu, S Hautaniemi and J Westermarck Oncogene 2012 31: 4266-4278; advance online publication, January 16, 2012; 10.1038/onc.2011.599 Abstract | Full Text | | | | The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasionK J Jeong, S Y Park, K H Cho, J S Sohn, J Lee, Y K Kim, J Kang, C G Park, J W Han and H Y Lee Oncogene 2012 31: 4279-4289; advance online publication, January 16, 2012; 10.1038/onc.2011.595 Abstract | Full Text | | | | Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcriptionK Kim, K W Jeong, H Kim, J Choi, W Lu, M R Stallcup and W An Oncogene 2012 31: 4290-4301; advance online publication, January 16, 2012; 10.1038/onc.2011.605 Abstract | Full Text | | | | RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cellsF-C Lin, Y-P Liu, C-H Lai, Y-S Shan, H-C Cheng, P-I Hsu, C-H Lee, Y-C Lee, H-Y Wang, C-H Wang, J Q Cheng, M Hsiao and P-J Lu Oncogene 2012 31: 4302-4316; advance online publication, January 9, 2012; 10.1038/onc.2011.596 Abstract | Full Text | | | | Inhibition of cell migration by PITENINs: the role of ARF6B Miao, I Skidan, J Yang, Z You, X Fu, M Famulok, B Schaffhausen, V Torchilin, J Yuan and A Degterev Oncogene 2012 31: 4317-4332; advance online publication, December 19, 2011; 10.1038/onc.2011.593 Abstract | Full Text | | | | Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafishS Camus, C Quevedo, S Menéndez, I Paramonov, P F W Stouten, R A J Janssen, S Rueb, S He, B E Snaar-Jagalska, L Laricchia-Robbio and J C Izpisua Belmonte Oncogene 2012 31: 4333-4342; advance online publication, December 19, 2011; 10.1038/onc.2011.594 Abstract | Full Text | | | | Advertisement | | Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function.
Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper. |
| | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | |
| | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | |
|
|
No comments:
Post a Comment